Procter & Gamble Hygiene and Health Care Limited

“PGHH owns two genuinely moated franchises — Whisper and Vicks — with 40%+ ROCE, zero debt, and a structural penetration growth runway in underpenetrated Indian markets. However, the 70.6%-controlling P&G parent extracts sustained value via ~5% royalties and dividend sweeps, leaving minority shareholders with a high-quality earnings stream but no reinvestment flywheel. At 44x trailing earnings, the stock prices in a best-case penetration scenario with no margin of safety; base-case 5-year annualized returns approximate 8%, which is inadequate given governance risk including a history of below-value delisting attempts. The stock has fallen ~33% from its 52-week high, making it directionally more interesting, but the entry price for a compelling risk/reward remains approximately 30–32x earnings (~INR 7,000–7,500). TRACK for a better entry rather than investing at current levels.”